InvestorsHub Logo
Followers 14
Posts 968
Boards Moderated 0
Alias Born 04/27/2012

Re: None

Friday, 05/20/2022 1:14:59 PM

Friday, May 20, 2022 1:14:59 PM

Post# of 17395
Aurinia Pharmaceuticals touts long-term benefit of Lupkynis for lupus

May 20, 2022 12:32 PM ETAurinia Pharmaceuticals Inc. (AUPH)By: Jonathan Block, SA News Editor6 Comments

Aurinia Pharmaceuticals (NASDAQ:AUPH) said that data from a study showed that its lupus nephritis treatment Lupkynis (voclosporin) led to preservation of kidney function over three years of treatment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News